# TumorGlow Intraoperative Molecular Imaging (IMI)

> **NCT04723810** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of Pennsylvania** · enrollment: 500 (estimated)

## Conditions studied

- Tumor, Solid

## Interventions

- **DRUG:** Indocyanine Green

## Key facts

- **NCT ID:** NCT04723810
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-14
- **Primary completion:** 2027-01-14
- **Final completion:** 2027-01-14
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04723810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04723810, "TumorGlow Intraoperative Molecular Imaging (IMI)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04723810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*